N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background/Aims : N-terminal pro-B-type natriuretic peptide (NT-proBNP) has recently been introduced as a useful marker in diagnosing underlying disease in patients with dyspnea and for determining the prognosis of patients with heart failure. The purpose of this study was to evaluate the value of the NT-proBNP as a marker of disease severity in patients with pericardial effusions. Methods : We enrolled 69 consecutive patients who showed moderate or large pericardial effusion with preserved left ventricular (LV) systolic function; 42 patients finally participated in the study, and 13 (31.0%) of them showed cardiac tamponade. We analyzed the etiologies, the clinical and echocardiographic variables, and the serum NT-proBNP levels in these patients. Results : The mean NT-proBNP level was 751±1002 ng/L (range 5 to 5289), and the median level was 385 ng/L (interquartile range 152 to 844). The NT-proBNP levels were higher in those patients with jugular venous distension (p=0.002), pulsus paradoxus (p=0.016), heart rate ≥100/min (p=0.006), cardiac tamponade (p=0.001), large pericardial effusion (p=0.029), exaggerated respiratory variation of the transmitral inflow (p=0.006), or plethora of the inferior vena cava (p=0.01). The NT-proBNP levels showed significant correlation with heart rate (r=0.517, p<0.001) and the diameter of the inferior vena cava (r=0.329, p=0.03). Conclusions : NT-proBNP may be useful as a marker of disease severity in patients suffering from pericardial effusion, but further prospective studies with more patients will be needed.
Abstract
Background/Aims : N-terminal pro-B-type natriuretic peptide (NT-proBNP) has recently been introduced as a useful marker in diagnosing underlying disease in patients with dyspnea and for determining the prognosis of patients with heart failure. The purpose of this study was to evaluate the value of the NT-proBNP as a marker of disease severity in patients with pericardial effusions. Methods : We enrolled 69 consecutive patients who showed moderate or large pericardial effusion with preserved left ventricular (LV) systolic function; 42 patients finally participated in the study, and 13 (31.0%) of them showed cardiac tamponade. We analyzed the etiologies, the clinical and echocardiographic variables, and the serum NT-proBNP levels in these patients. Results : The mean NT-proBNP level was 751±1002 ng/L (range 5 to 5289), and the median level was 385 ng/L (interquartile range 152 to 844). The NT-proBNP levels were higher in those patients with jugular venous distension (p=0.002), pulsus paradoxus (p=0.016), heart rate ≥100/min (p=0.006), cardiac tamponade (p=0.001), large pericardial effusion (p=0.029), exaggerated respiratory variation of the transmitral inflow (p=0.006), or plethora of the inferior vena cava (p=0.01). The NT-proBNP levels showed significant correlation with heart rate (r=0.517, p<0.001) and the diameter of the inferior vena cava (r=0.329, p=0.03). Conclusions : NT-proBNP may be useful as a marker of disease severity in patients suffering from pericardial effusion, but further prospective studies with more patients will be needed.
참고문헌 (34)
- Goldstein JA, "Cardiac tamponade, constrictive pericarditis, and restrictive cardiomyopathy", Current Problems in Cardiology, 29, pp.503~567 (2004)
- Spodick DH, "Acute cardiac tamponade", New England Journal of Medicine, 349, pp.684~690 (2003)
- Little WC, "Pericardial disease", Circulation, 113, pp.1622~1632 (2006)
- Levin ER, "Natriuretic peptides", New England Journal of Medicine, 339, pp.321~328 (1998)
- Hall C, "Essential biochemistry and physiology of (NT-pro) BNP", EUROPEAN JOURNAL OF HEART FAILURE, 6, pp.257~260 (2004)
- Maisel AS, "Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure", New England Journal of Medicine, 347, pp.161~167 (2002)
- Mair J, "The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 39, pp.571~588 (2001)
- Tschope C, "The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements", EUROPEAN HEART JOURNAL, 26, pp.2277~2284 (2005)
- Kragelund C, "N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease", New England Journal of Medicine, 352, pp.666~675 (2005)
- Omland T, "N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes", Circulation, 106, pp.2913~2918 (2002)
- Gardner RS, "N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure", EUROPEAN HEART JOURNAL, 24, pp.1735~1743 (2003)
- Sagrista-Sauleda J, "Clinical clues to the causes of large pericardial effusions", AMERICAN JOURNAL OF MEDICINE, 109, pp.95~101 (2000)
- Gottdiener JS, "American Society of Echocardiography recommendations for use of echocardiography in clinical trials", Journal of the American Society of Echocardiography, 17, pp.1086~1119 (2004)
- Kronzon I, "Diastolic atrial compression: a sensitive echocardiographic sign of cardiac tamponade", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2, pp.770~775 (1983)
- Armstrong WF, "Diastolic collapse of the right ventricle with cardiac tamponade: an echocardiographic study", Circulation, 65, pp.1491~1496 (1982)
- Himelman RB, "Inferior vena cava plethora with blunted respiratory response: a sensitive echocardiographic sign of cardiac tamponade", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 12, pp.1470~1477 (1988)
- Appleton CP, "Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied by Doppler echocardiography", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 11, pp.1020~1030 (1988)
- Burstow DJ, "Cardiac tamponade: characteristic Doppler observations", MAYO CLINIC PROCEEDINGS, 64, pp.312~324 (1989)
- Spodick DH, "Low atrial natriuretic factor levels and absent pulmonary edema in pericardial compression of the heart", AMERICAN JOURNAL OF CARDIOLOGY, 63, pp.1271~1272 (1989)
- Fernandes F, "NT pro-BNP levels in pericardial diseases and how they are used as complementary evaluation method of diastolic restriction: initial experience: 25 cases", Arquivos Brasileiros de Cardiologia, 86, pp.175~180 (2006)
- Schrier RW, "Hormones and hemodynamics in heart failure", New England Journal of Medicine, 341, pp.577~585 (1999)
- Hanford DS, "Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes", JOURNAL OF BIOLOGICAL CHEMISTRY, 269, pp.26227~26233 (1994)
- de Lemos JA, "B-type natriuretic peptide in cardiovascular disease", Lancet, 362, pp.316~322 (2003)
- Liang F, "Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase", Hypertension, 35, pp.188~192 (2000)
- Vinch CS, "Paradoxical changes in brain natriuretic peptide levels and loading conditions after intravenous conscious sedation", Journal of the American Society of Echocardiography, 17, pp.1191~1196 (2004)
- Shaver JA, "Noninvasive", invasive correlates of exaggerated ventricular interdependence in cardiac tamponade, 2001, pp.37(1), 71~76
- Reddy PS, "Spectrum of hemodynamic changes in cardiac tamponade", AMERICAN JOURNAL OF CARDIOLOGY, 66, pp.1487~1491 (1990)
- Goetze JP, "Increased cardiac BNP expression associated with myocardial ischemia", FASEB JOURNAL, 17, pp.1105~1107 (2003)
- Grose R, "Cardiac tamponade in dogs with normal coronary arteries: I. effect of changing intravascular volume on hemodynamics and myocardial blood flow", BASIC RESEARCH IN CARDIOLOGY, 79, pp.531~541 (1984)
- Zipes DP, "text book of cardiovascular medicine", pp.525~ (2005), Elservier Saunders
- Martins JB, "Can cardiac tamponade be diagnosed by echocardiography?: experimental studies", Circulation, 60, pp.737~742 (1979)
- Ommen SR, "Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study", Circulation, 102, pp.1788~1794 (2000)
- Min PK, "Incremental value of measuring the time difference between onset of mitral inflow and onset of early diastolic mitral annulus velocity for the evaluation of left ventricular diastolic pressures in patients with normal systolic function and an indeterminate E", E', 2007, pp.100, 326~330
- Mottram PM, "Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function", AMERICAN JOURNAL OF CARDIOLOGY, 92, pp.1434~1438 (2003)
